To estimate the relative significance of exogenous vs . endogenous fatty acids in increasing hepatic triacylglycerol secretion following an inhibition of fatty acid oxidation by emeriamine , livers from 2 -d-fasting rats were perfused with or without an inhibitor in the p resence of a geometrical isomer of linoleate (linolelaidic acid , trans,trans-9, 12 -octadecadienoic acid) . Emeriamine added to the perfusion medium at 2h of the recirculating perfusion period caused immediate and complete cessation of ketone body production while it increased triacylglycerol and cholesterol secretion by the liver without affecting uptake of exogenous linolelaidic acid. The increase in the triacylglycerol secretion by emeriamine was accompanied by a marked increase in the proportion of linolelaidic acid in this lipid molecule in the perfusate and in the liver . The calculated amounts of exogenous linolelaidate , compared with those of endogenous fatty acids in the secretory triacylglycerol , suggested that the former compared with the latter contributes more to the drug-mediated increase in triacylglycerol secretion . This drug caused a marked reduction of mitochondrial carnitine palmitoyltransferase activity in perfused liver . These results suggest that a blockade of fatty acid oxidation by emeriamine , through an inhibition of carnitine palmitoyltransferase , diverts pred ominantly the exogenous free fatty acids from oxidation to the esteri fication pathway and subsequently stimulates the synthesis and secretion * To whom correspondence should b e addressed.
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It is considered that the fatty acid oxidation rate is a critical determinant in regulating hepatic triacylglycerol synthesis and secretion in the rat (1, 2). Our previous studies using an inhibitor of mitochondrial fatty acid oxidation, emeriamine [(R)-3-amino-4-trimethylaminobutyric acid], support this hypothesis. This drug is a specific and potent inhibitor of carnitine palmitoyltransferase I and thus reduces fatty acid oxidation rate through the retardation of the transportation of fatty acids across the mitochondrial membrane (3-5). We previously reported that the inhibi tion of fatty acid oxidation by emeriamine increases triacylglycerol and cholesterol secretion in isolated liver perfused with oleic acid substrate in 2-d-fasting rats (6). Furthermore, the oral administration of emeriamine caused hypertriglyceridemia and an accumulation of hepatic triacylglycerol in fasting rats (7, 8) . However, in the previous liver perfusion study we did not assess the relative contribution of endogenous and exogenous fatty acids to the emeriamine-induced stimulation of triacylglycerol secretion.
In this experiment, we therefore compared the metabolism of a geometrical isomer of linoleate (linolelaidate, traps, traps-9, 12-octadecadienoic acid) between perfused rat liver treated with this inhibitor and without it. This geometrical isomer of linoleate was chosen as a tracer to examine the metabolic fate of exogenous fatty acid in perfused rat liver because of its rare occurrence in nature, and it is dis tinguishable from other endogenous fatty acids and quantifiable by gas-liquid chromatography on Silar 10 C column (9, 10). The proportion of linolelaidic acid in perfusate triacylglycerol at each time interval was determined by gas-liquid chromatography (Table 2 ). In perfusate obtained from control liver at 1h of the perfusion period, the proportion of the transfatty acid in triacylglycerol was 26%, and it gradually decreased to 16% at the end of perfusion. The difference between 1h and 4h being statistically significant at p<0.05. This result suggests that 74-84% of perfusate-triacylglycerol fatty acids are derived from endogenous origins in control livers during the entire experimental period. Emeriamine treatment at 2h caused a marked increase in the proportion of exogenous transfatty acid in perfusate triacylglycerol. The increase in the value was already apparent at 3h of the experimental period (17.8% for the control and 41.9% for the drug-treated livers, the difference being statistically significant at p<0.05).
Based on the analysis by gas-liquid chromatography of fatty acids , the amounts of exogenous transfatty acid and endogenous fatty acids secreted as components of perfusate triacylglycerol were calculated (Table 2) . Although linolelaidic acid was detectably found to exist in perfusate triacylglycerol at 1h of the perfusion period, it gradually decreased thereafter during the entire experimental period in control livers. Also, no cumulative increase in the secretion of triacylglycerol enriched with endogenous fatty acids was observed during the entire experimental period in control liver. The addition of emeriamine at 2h caused an immediate and marked increase in the secretion of linolelaidate as triacylglycerol into liver perfusate (4.3-fold at 3 h and 10-fold at 4 h, compared with the value at 2h). This drug also caused an increased secretion of endogenous fatty acids as perfusate triacylglycerol (1.5-fold at 3h and 2.4-fold at 4h, compared with the value at 2h), but the extent of the increases was more moderate than that of exogenous fatty acid .
In contrast to the situation in triacylglycerol secretion , cholesterol was con tinuously accumulated in the perfusion medium during the entire experimental period, even in the control liver. Emeriamine added at 2h of the experimental period magnified the extent of cholesterol accumulation in liver perfusate. Con sequently the drug treatment significantly increased the amount of cholesterol secreted by the liver at 3h and 4h of the experimental period . The extent of the increase by emeriamine was, however , much less in cholesterol secretion than in triacylglycerol secretion.
Incorporation of exogenous transfatty acid into various lipids
As shown in Table 3 , the drug treatment caused a marked increase in the proportion of transfatty acid in hepatic triacylglycerol. The proportion of transfatty acid in triacylglycerol was, however, significantly lower in the liver than in perfusate for the control and the drug-treated groups (p<0.05) . The percentages of exogenous transfatty acid in cholesterol ester and phospholipid in perfusates and postperfused livers of control rats were very low. However, an inhibition of fatty acid oxidation by emeriamine was associated with a concomitant increase in the incorporation of exogenous transfatty acid into perfusate and hepatic phospholipid . The drug also caused a marked increase in the proportion of transfatty acid in cholesterol ester in perfusate, but not in postperfused liver.
DISCUSSION
This study was carried out to examine the relative significance of the endogenous and/or exogenous-free fatty acids as the substrate for the increased synthesis and secretion of lipids, especially triacylglycerol , by the 2-d fasting rat liver following inhibition of fatty acid oxidation by emeriamine , a specific inhibitor of liver mitochondrial carnitine palmitoyltransferase I. For this purpose , we (20, 21) . Moreover, Ide and Ontko reported that the contribution of exogenous fatty acid can be more than 80% of total ketone body production (21) . Therefore the impaired triacylglycerol secretion and the reduced incorporation of exogenous transfatty acid into triacylglycerol molecule by the livers of fasting rats may be caused by a depletion of exogenous fatty acids available for the synthesis and secretion of triacylglycerol through the stimulation of fatty acid oxidation , but not by any defects involved in the esterification pathway . The inhibition of fatty acid oxidation by emeriamine increased the proportion of linolelaidic acid accompanying the concomitant decreases in the proportions of endogenous fatty acids such as palmitic, palmitoleic, stearic, and oleic acids , but not linoleic acid in perfusate triacylglycerol (Table 2 ). Furthermore, discrimination by gas liquid chromatography of endogenous fatty acids from exogenous fatty acids can allow us to estimate that exogenous fatty acid compared with the endogenous fatty acid serves as the preferred substrate for the formation and secretion of triacylglycerol-rich lipoproteins when the fasting rat livers have been treated with fatty acid oxidation inhibitor. Fatty acid analyses also showed that the inhibition of fatty acid oxidation by emeriamine diverts exogenous fatty acid primarily to triacylglycerol and to a lesser extent to cholesterol ester and phospholipid (Table  3) , consistent with a previous study using 2-tetradecylglycidic acid (TDGA) as an inhibitor of fatty acid oxidation (21) .
Emeriamine treatment increased the proportions of exogenous transfatty acid in triacylglycerol and cholesterol ester, but not in phospholipid, more in perfusate than in the postperfused liver, suggesting that free fatty acid supplied exogenously during the perfusion periods incorporates into hepatic triacylglycerol and cholesterol ester, and it is preferentially secreted in the form of lipoprotein instead of being stored in the liver.
The mechanisms responsible for an increased hepatic secretion of cholesterol following inhibition of fatty acid oxidation remain obscure . It has been reported that impairment of fatty acid oxidation at the step of carnitine palmitoyltransferase by the inhibitors, such as carnitine analogues or TDGA, greatly stimulated the cholesterol-synthesizing capacity of the liver, which is accompanied by an increased secretion of cholesterol by the liver (21, 22) . Goh and Heimberg also reported that increased secretion of triacylglycerol following the infusion of exogenous oleic acid resulted in a simultaneous enhancement of the activity of hepatic cholesterol synthesizing enzymes and the secretion of cholesterol (23, 24) . It is therefore likely that the increased hepatic secretion of cholesterol following inhibition of fatty acid oxidation by emeriamine is, in part, attributed to an enhancement of the cholesterol synthesis de novo in the liver, although the effect of emeriamine on hepatic cholesterol synthesis remains to be investigated.
In summary, we demonstrated again that the fatty acid oxidation rate is crucial for the synthesis and secretion of triacylglycerol-rich lipoproteins in rat liver .
